Comparison

SARS-CoV-2 (COVID-19) NSP14 (ExoN) Antibody

Item no. PRS-9187-0.02mg
Manufacturer ProSci
Amount 0.02 mg
Quantity options 0.02 mg 0.1 mg
Category
Type Antibody Primary
Format Liquid
Applications ELISA
Specific against Virus
Host Rabbit
Isotype IgG
Conjugate/Tag Unconjugated
Citations Gorbalenya. bioRxiv: 2020.
Hui et al. Int J Infect Dis. 2020;91:264-266.
Minskaia et. al. Proc. Natl. Acad. Sci. U.S.A 2006; 103:5108-5113
Bouvet et. al. PLoS Pathog. 2010; 6:E1000863-E1000863
Bouvet et. al. Proc. Natl. Acad. Sci. U.S.A. 2012;109:9372-9377
Denison et. al. RNA Biol. 2011;8:270-279
Smith et. al. PLoS Pathog. 2013;9:e1003565-e1003565
Agostini et. al. MBio 2018; 9:0-0
NCBI ExoN
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias Proofreading exoribonuclease,Guanine-N7 methyltransferase,Non-structural protein 14,NSP14.
Shipping Condition Cool pack
Available
Manufacturer - Type
Primary Antibodies
Shipping Temperature
Blue Ice
Storage Conditions
SARS-CoV-2 (COVID-19) NSP14 (ExoN) antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Manufacturer - Research Area
Infectious Disease, COVID-19
Background
Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP14 (ExoN) is an enzyme possessing two different activities: an exoribonuclease activity acting on both ssRNA and dsRNA in a 3' to 5' direction and a N7-guanine methyltransferase activity (3, 4, 5). It acts as a proofreading exoribonuclease for RNA replication, thereby lowering The sensitivity of the virus to RNA mutagens(6, 7, 8).
By Type
Infectious Disease, COVID-19
Badges
Trial Size, New
Protein Gi #
1802476817
Purification
SARS-CoV-2 (COVID-19) NSP14 (ExoN) Antibody is affinity chromatography purified via peptide column.
Concentration
1 mg/mL
Buffer
SARS-CoV-2 (COVID-19) NSP14 (ExoN) Antibody is supplied in PBS containing 0.02% sodium azide.
Application Note
Antibody validated: SARS-CoV-2 (COVID-19) NSP14 (ExoN) antibody can detect 2 ng of free peptide at 1 μ g/mL in ELISA.
Homology
Predicted reactivity based on immunogen sequence: SARS-CoV NSP14 (ExoN) protein: (79%).
Immunogen
Anti-SARS-CoV-2 (COVID-19) NSP14 (ExoN) antibody (9187) was raised against a peptide corresponding to 14 amino acids near the center of SARS-CoV-2 (COVID-19) NSP14 (ExoN) protein.

The immunogen is located between 30-80 amino acids of SARS-CoV-2 (COVID-19) NSP14 (ExoN).
Clonality
Polyclonal
NCBI Official Name
ORF1a polyprotein; ORF1ab polyprotein
NCBI Organism
Severe acute respiratory syndrome coronavirus 2
Disclaimer
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
User Note
Optimal dilutions for each application to be determined by the researcher.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.02 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close